本页面由Tiger Trade Technology Pte. Ltd.提供服务

Olema Pharmaceuticals, Inc.

23.65
+0.28001.20%
盘前23.760.1100+0.47%06:54 EST
成交量:183.79万
成交额:4,290.19万
市值:18.60亿
市盈率:-13.09
高:23.78
开:23.48
低:22.40
收:23.37
52周最高:36.26
52周最低:2.86
股本:7,865.99万
流通股本:5,314.44万
量比:1.29
换手率:3.46%
股息:- -
股息率:- -
每股收益(TTM):-1.8064
每股收益(LYR):-2.2041
净资产收益率:-59.22%
总资产收益率:-34.41%
市净率:6.05
市盈率(LYR):-10.73

数据加载中...

公司资料

公司名字:
Olema Pharmaceuticals, Inc.
交易所:
NASDAQ
成立时间:
2006
员工人数:
122
公司地址:
780 Brannan Street,San Francisco,California,United States
邮编:
94103
电话:
传真:
- -
简介:
Olema Pharmaceuticals, Inc.位于加利福尼亚州的旧金山,于2006年8月7日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司,致力于发现,开发和商业化针对女性癌症的下一代靶向疗法。

董事

名称
职位
Sean Bohen
President,Principal Financial Officer,Chief Executive Officer and Director
Ian Clark
Chairperson of the Board
Andrew Rappaport
Director
Cynthia Butitta
Director
Cyrus L. Harmon
Director
Gorjan Hrustanovic
Director
Graham Walmsley
Director
Sandra Horning
Director
Scott Garland
Director
Yi Larson
Director

股东

名称
职位
Sean Bohen
President,Principal Financial Officer,Chief Executive Officer and Director
David C. Myles
Chief Discovery and Non-Clinical Development Officer
Naseem Zojwalla
Chief Medical Officer
Shawnte M. Mitchell
Chief Legal Officer and Corporate Secretary